A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late Onset Pompe Disease (PROGRESS-GT LOPD)

​ Conditions: Pompe Disease (Late-onset); Pompe Disease Late-Onset; LOPD

Interventions: Genetic: AB-1009 (GAA Gene)

Sponsors: AskBio Inc; Bayer

Not yet recruiting Conditions: Pompe Disease (Late-onset); Pompe Disease Late-Onset; LOPD
Interventions: Genetic: AB-1009 (GAA Gene)
Sponsors: AskBio Inc; Bayer
Not yet recruiting